首页> 外国专利> PRODUCTION OF RECOMBINANT TYPE HUMAN ANGIOTENSINOGEN

PRODUCTION OF RECOMBINANT TYPE HUMAN ANGIOTENSINOGEN

机译:重组型人血管紧张素原的产生

摘要

PURPOSE:To enable obtaining of the subject substance in a large amount and good yield by inserting a specific vector into a cell according to a calcium phosphate method and then culturing the resultant cell in a culture medium for growing the cells. CONSTITUTION:A recombinant type human angiotensinogen cDNA is integrated into cleaved sites of an expression vector in an animal cultured cell with restriction enzymes BamHI/EcoRV to provide an expression vector pSVHagD (A), which is then inserted into an animal cell (dhfr-deficient strain, DXB-11) of a Chinese hamster ovary (CHO) cell, etc., in the presence of 0.5-1.0M calcium phosphate to afford an inserted cell (D). The resultant cell (B) is subsequently cultured in a culture medium prepared by slowly adding aminopterin so as to provide 50-1000nM concentration thereof at about 37 deg.C for a desired number of days to afford a culture supernatant (C). The ingredient (C) is then purified by a salting out, affinity chromatography, isoelectric focusing method, etc., to produce a recombinant type human angiotensinogen.
机译:目的:通过将特定的载体根据磷酸钙方法插入细胞中,然后在培养液中培养所得细胞以使其生长,从而能够以高产量获得目标物质。组成:重组型人血管紧张素原cDNA通过限制酶BamHI / EcoRV整合到动物培养细胞中表达载体的切割位点,以提供表达载体pSVHagD(A),然后将其插入动物细胞(dhfr缺陷型)在0.5-1.0M磷酸钙的存在下,将中国仓鼠卵巢(CHO)细胞等细胞株(DXB-11)等分离,得到插入的细胞(D)。随后将所得细胞(B)在通过缓慢添加氨基蝶呤而制备的培养基中培养,以在约37℃下提供其50-1000nM浓度达所需天数,从而提供培养上清液(C)。然后通过盐析,亲和色谱,等电聚焦法等纯化成分(C),以产生重组型人血管紧张素原。

著录项

  • 公开/公告号JPH03277294A

    专利类型

  • 公开/公告日1991-12-09

    原文格式PDF

  • 申请/专利权人 SAITETSUKU RISAACHI:KK;

    申请/专利号JP19900077031

  • 发明设计人 MURAKAMI KAZUO;

    申请日1990-03-28

  • 分类号C12N15/09;C12N15/16;C12P21/02;C12R1/91;

  • 国家 JP

  • 入库时间 2022-08-22 05:37:25

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号